Effect of highly active anti-retroviral therapy on CD3+/CD4+/CD8+ T lymphocyte counts in HIV seropositive Kashmiri patients: A follow up study

Indian Journal of Pathology and Microbiology

Volumn 50, Issue 3, 2007, Pages 648-651

  Shah, Zafar A ^a,b   Rasool, Roohi ^a   Siddiqi, Mushtaq A ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^b Skims

Author keywords

ARV; CD3+; CD4+; CD8+ T lymphocytes; HIV

Indexed keywords

CD3 ANTIGEN; INDINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LYMPHOCYTE COUNT; MALE; PRESCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; ANTI-HIV AGENTS; ANTIGENS, CD3; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HIV-1; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME;

EID: 34548238637     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hubrich R H, Little S J, Currier J S et al. The value of patient reported adherence to anti retroviral therapy is predicting virologic and immunologic response. California collaborative treatment group. AIDS 1999; 13:1099-1107
2. O' Brian WA, Hartigan PM, Daar S, Simberkoff MS, Hamilton JD. Changes in plasma HIV RNA levels and CD4+ lymphocytes counts predict both response to anti retroviral therapy and therapeutic failure. Ann Intern Med 1997, 126:939-45.
3. Kannangai R, Ramalingam S, Vijay Kumar TS et al. The immunological and virological response in human immunodeficiency virus type-1 (HIV-1) infected Indian individuals on HAART therapy. One year follow up study. Indian J Med Microbiol 2003; 21(4):274-6.
4. DeHovitz JA , Kovacs A, Feldman JG et al . The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the women's interagency HIV study. J Infect Dis 2000; 182:1527-30.
5. Hammer SM, Squires KE, Hughes MD et al. A controlled trial of two nucleoside analogues plus Indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cumm or less. N Engl J Med 1997; 337:725-33.
6. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by base line CD4 count and viral load after initiating triple drug therapy. JAMA 2001: 286:2568-77.
7. Nicholson JKA, Jones BM, Hubbard M. CD4 T lymphocyte determinations on whole blood specimens using a single tube three colour assay. Cytometry 1993; 14:685-9.
8. Centres for disease control. Revised guidelines for performing CD4+ T cell determinations in persons with HIV. MMWR. 1997; 46 (No. RR-2 ); 1-29.
9. Centres for disease control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41(No. RR-17); 1-19.
10. Kaufman D, Pantaleo G, Sudre P, Telenti A. For the Swiss HIV cohort study CD4 cell count in HIV-1 infected individuals remaining viraemic with highly active anti retroviral therapy (HAART). Lancet 1998; 351:723-4.
11. Deeks SG, Hecht FM, Swanson M et al. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy. AIDS 1999; 13:F35-43.
12. 6/ 1. AIDS 2002; 16(10):1371-81.
13. Shahapur PR , Bary I, Shivanananda PG. Effect of HAART on CD4+ T lymphocyte counts in HIV seropositive South Indian individuals. A follow up study. Indian J Pathol Microbiol 2005; 48:270-2.
14. Ledergerber B, Opravil M, Egger M, et al. Clinical progression and virological failure on highly active anti retroviral therapy in HIV-1 patients. Prospective cohort study. Lancet 1999; 353:863-8.
15. Lucas GM, Caisson RE, Moore RD. Highly active anti retroviral therapy in large urban clinic: risk factor for virologic failure and adverse drug reactions. Ann Intern Med 1999; 131:81-7.
16. Yarchoan R, Venzon DJ, Pluda JM, et al. CD4 count and the risk for death in patients infected with HIV receiving anti retroviral therapy. Ann Intern Med 1991; 115:184-9.